Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,536 shares at $454.84 ($1.1M) on 2025-10-02, disclosed to the SEC on 2025-10-03.
Open-market sale of $1.1M ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $446.53 | 55 | $25K | 2.1% |
| 2 | $447.92 | 27 | $12K | 1.1% |
| 3 | $448.77 | 86 | $39K | 3.4% |
| 4 | $449.79 | 119 | $54K | 4.7% |
| 5 | $449.79 | 119 | $54K | 4.7% |
| 6 | $450.81 | 260 |
| $117K |
| 10.2% |
| 7 | $450.81 | 260 | $117K | 10.2% |
| 8 | $451.86 | 159 | $72K | 6.3% |
| 9 | $451.86 | 159 | $72K | 6.3% |
| 10 | $452.69 | 319 | $144K | 12.6% |
| 11 | $452.69 | 319 | $144K | 12.6% |
| 12 | $453.77 | 157 | $71K | 6.2% |
| 13 | $453.77 | 157 | $71K | 6.2% |
| 14 | $454.84 | 117 | $53K | 4.6% |
| 15 | $454.84 | 117 | $53K | 4.6% |
| 16 | $455.82 | 35 | $16K | 1.4% |
| 17 | $457.43 | 70 | $32K | 2.8% |
| 18 | $457.64 | 1 | $458 | 0.0% |
| Total | $452.12 avg | 2,536 | $1.1M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-09-02 | $3.1M | — | Filing → |